AzTrials
AzTrials

Rheumatoid ArthritisRAEUSNCT02351401

Rheumatoid Arthritis Through Education and US Study (RAEUS)

A study testing Education using ultrasonography as feedback tool in people with Rheumatoid Arthritis, run by National University Hospital, Singapore.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Patients can potentially monitor disease activity of rheumatoid arthritis (RA) through self-assessed swollen joints (clinical synovitis)joint counts but reliability of joint swelling is poor. Read more about this study

Who is it for?
Ages 21 to 80 years
Conditions the study is for
Rheumatoid Arthritis
What is being tested?
Education using ultrasonography as feedback tool
Could I receive a placebo?
No, everyone receives an active treatment
How many people
101 participants
Where
No sites listed yet
Study dates
Nov 2011to Oct 2013
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 21 to 80 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • RA patients fulfilling ACR1987 criteria
  • adults between age 21 and 80 years

Who cannot join

  • pregnant
  • no mental health illness
  • fit to perform informed consent

About this study

Official title: Improvement in Patient Awareness and Ability to Assess Disease in Rheumatoid Arthritis: Rheumatoid Arthritis Through Education and US Study (RAEUS)

Patients can potentially monitor disease activity of rheumatoid arthritis (RA) through self-assessed swollen joints (clinical synovitis)joint counts but reliability of joint swelling is poor. The objective is to evaluate the use of education by ultrasound feedback on the ability of patients to assess for clinical synovitis swollen joints in RA.

Read the detailed description

Design: 6-month single centre randomized controlled trial. Patients: established RA. Intervention: education on self-assessment of joints that included initial brief patient training on tender (TJC) and swollen (SJC) joint counts, followed by US feedback every 3 months versus standard care without education. Patient and physician independently performed 28-joint counts at each visit. Outcome variables: (Primary) Percentage of patients with good agreement with physician derived swollen joints (prevalence-adjusted bias adjusted kappa, PABAK>0.6). Other variables: Agreement in SJC (Bland and Altman 95% limits of agreement), feasibility/patient satisfaction survey and disease activity score (DAS28) at 6 months.

Being tested
Education using ultrasonography as feedback tool
Medical subject headings
Arthritis, Rheumatoid

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Education using ultrasonography as feedback toolBehavioural

    Education using ultrasonography as feedback tool

Study groups in NCT02351401
Study groupRoleWhat they receive
Education with ultrasonographyExperimentalIntervention includes education of self-assessment of synovitis using ultrasonography as a feedback training tool
Receives: Behavioral: Education using ultrasonography as feedback tool
Standard CareNo interventionNormal standard care where patients are not taught how to self-assess for synovitis, without ultrasonography a training tool

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. prevalence-adjusted bias adjusted kappa, PABAK>0.6

    Measured: at 6 months

Secondary outcomes (3)
  1. Bland and Altman 95% limits of agreement

    swollen joint count agreement

    Measured: 6 months

  2. Level of satisfaction

    Likert response, satisfaction survey

    Measured: 6 months

  3. disease activity score in 28 joints (DAS28)

    composite score that measures disease activity incorporating tender joint count, swollen joint count, erythrocyte sedimentation rate and patient global assessment

    Measured: 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted30 Jan 2015 (estimated)
  2. Study startNov 2011
  3. Primary completionNov 2012
  4. Study completionOct 2013

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
101 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02351401
Sponsor's protocol ID
2011/01611
Acronym
RAEUS
Status last verified
Jan 2015
First submitted
12 Jan 2015
Last updated
30 Jan 2015
Results posted
No
Data monitoring committee
No

Publications

  • Cheung PP, Lahiri M, Teng GG, Lim AY, Lau TC, Lateef A, Mak A, Gossec L, March L. A randomized controlled trial for improving patient self-assessment of synovitis in rheumatoid arthritis with education by ultrasonography: the RAEUS Study. Rheumatology (Oxford). 2015 Jul;54(7):1161-9. doi: 10.1093/rheumatology/keu447. Epub 2014 Dec 3.

    PubMed 25477057

Questions about this trial

What is this clinical trial studying?

A study testing Education using ultrasonography as feedback tool in people with Rheumatoid Arthritis, run by National University Hospital, Singapore.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 30 Jan 2015. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

prevalence-adjusted bias adjusted kappa, PABAK>0.6 (time frame: at 6 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02351401, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Jan 2015.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in